FDA Inspection 990107 — Taizhou Taifa Pharmaceuticals Co., Ltd.
The FDA completed an inspection of Taizhou Taifa Pharmaceuticals Co., Ltd. on September 15, 2016 in Xianju, Taizhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- September 15, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Xianju, Taizhou (China)